Skip to main content
Equibles

Allianz Asset Management GmbH

Position in BMY — Bristol Myers Squibb Co

CIK 1535323 MUNICH, 2M
Back to BMY Full portfolio

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$476,828,662
+$59,564,913 QoQ
Shares Held
8,275,402
+20.3% QoQ
Ownership
0.405%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#36
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 66% Shared 0% None 34%

Common Shares in BMY Over Time

Shares Held

Position Value (USD)

Derivatives in BMY

reported options exposure · as of Jun 30, 2026
CallValue
$6,015,528
CallShares
104,400
PutValue
$7,018,116
PutShares
121,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $5,256,144,156 across 13 Drug Manufacturers - General names. BMY ranks #5 (9.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AZN
Astrazeneca PLC
 6,830,190 $1,295,140,626
2 JNJ
Johnson & Johnson
 4,873,739 $1,237,783,491
3 LLY
ELI LILLY & Co
 477,197 $572,364,441
4 MRK
Merck & Co., Inc.
 3,713,343 $477,164,575
5 BMY
Bristol Myers Squibb Co
This page 		8,275,402 $476,828,662
6 ABBV
AbbVie Inc.
 1,566,077 $394,087,615
7 GILD
Gilead Sciences, Inc.
 2,853,184 $360,471,266
8 AMGN
Amgen Inc
 636,542 $230,504,586

All Filings in BMY

Export CSV
46 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $476,828,662 8,275,402
2026-06-30 $7,018,116 121,800
2026-06-30 $6,015,528 104,400
2026-03-31 $417,263,749 6,879,864
2026-03-31 $5,282,615 87,100
2026-03-31 $6,823,125 112,500
2025-12-31 $296,421,120 5,495,386
2025-12-31 $5,226,786 96,900
2025-12-31 $4,185,744 77,600
2025-09-30 $3,373,480 74,800
2025-09-30 $2,575,210 57,100
2025-09-30 $234,382,534 5,196,952
2025-06-30 $4,068,891 87,900
2025-06-30 $6,216,747 134,300
2025-06-30 $209,084,336 4,516,836
2025-03-31 $4,293,696 70,400
2025-03-31 $199,504,813 3,271,107
2025-03-31 $3,147,084 51,600
2024-12-31 $193,574,563 3,422,464
2024-12-31 $3,535,000 62,500
2024-12-31 $1,397,032 24,700
2024-09-30 $3,156,140 61,000
2024-09-30 $78,758,470 1,522,197
2024-09-30 $5,080,868 98,200
2024-06-30 $2,192,784 52,800
2024-06-30 $61,599,994 1,483,265
2024-06-30 $1,686,118 40,600
2024-03-31 $103,119,806 1,901,527
2024-03-31 $189,805 3,500
2024-03-31 $119,306 2,200
2023-12-31 $88,470,443 1,724,234
2023-09-30 $87,845,859 1,513,540
2023-06-30 $111,842,984 1,748,913
2023-03-31 $136,705,448 1,972,377
2022-12-31 $135,836,850 1,887,934
2022-09-30 $123,237,072 1,733,536
2022-06-30 $189,601,874 2,462,362
2022-03-31 $96,878,966 1,326,564
2021-12-31 $107,450,620 1,723,346
2021-09-30 $129,755,844 2,192,933
2021-06-30 $149,133,819 2,231,874
2021-03-31 $133,138,580 2,108,959
2020-12-31 $274,689,619 4,428,335
2020-09-30 $270,822,979 4,492,005
2020-06-30 $405,701,947 6,899,693
2020-03-31 $336,947,407 6,044,984

Report a Problem

Category
Description
Email (optional, for follow-up)